Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma
Clinical trial NCT02535078 · WITHDRAWN
Trial details
- NCT number
- NCT02535078
- Sponsor
- Immunocore Ltd
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2023-06-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.